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The stability of a drug is an important factor in
ensuring its quality.
The studied combined ear drops have an increased
tendency of degradation, which requires an extensive
stability study and obtaining data to determine the
shelf life and establish the storage conditions.
The purpose. Stability studies of ear drops
containing ciprofloxacin, dexamethasone, loratadine
and volatile basil oil.
ICH Q1A (R2) stability testing methodology; 3
series of ear drops; reference standards for the active
substances (Sigma Aldrich, USA); Shimadzu LC-
20AD liquid chromatograph with UV-VIS detector;
Fungilab Smart R viscometer; pH meter inoLab 7110;
solvents, reagents in accordance with the European
Pharmacopoeia.
Ciprofloxacin is stable in acid medium, degrades in
alkaline medium after 3 hours (approximately 10.0%),
under oxidation (19.7%) and light action (17.1%).
Dexamethasone degrades in acid medium (by
7.7%) and under oxidation (by 19.9%), it is stable in
alkaline medium and under the action of light.
Loratadine degrades in acid medium (by 3.0%), is
stable in alkaline medium, under oxidation and action
of light.
In real-time storage conditions (25°C±2°C and RH
60%±5%), it was found that the pharmaceutical form
did not change its quality parameters for 24 months.
The stability studies under stress and in real time conditions allowed us to select the packaging, the optimal storage
conditions and to establish the provisional shelf life for the combined auricular pharmaceutical form during 2 years.





Figure 1. Modification of the concentration of active 
ingredients following stress degradation Table 1. The result of real-time ear drops stability studies
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Ciprofloxacin degradation in stress conditions
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Dexamethasone degradation in stress conditions
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Loratadine degradation in stress conditions




















ANALYZED PARAMETERS AND ADMISSIBILITY CONDITIONS
Appearance
milky suspension, 
with a yellowish shade,


























0 Corresponds Corresponds 5.5 25.7 0.30012 0.02000 0.02010
3 Corresponds Corresponds 5.5 25.8 0.30010 0.02001 0.02009
6 Corresponds Corresponds 5.4 25.8 0.30009 0.02000 0.02000
9 Corresponds Corresponds 5.5 25.8 0.29999 0.02000 0.01995
12 Corresponds Corresponds 5.6 25.7 0.29996 0.01999 0.01979
18 Corresponds Corresponds 5.7 25.9 0.29950 0.01998 0.01977
24 Corresponds Corresponds 5.7 25.9 0.29949 0.01997 0.01976
Batch 2
0 Corresponds Corresponds 5.6 27.4 0.30012 0.02000 0.01958
3 Corresponds Corresponds 5.6 27.4 0.30013 0.02001 0.01957
6 Corresponds Corresponds 5.4 27.5 0.30010 0.02000 0.01958
9 Corresponds Corresponds 5.5 27.5 0.29952 0.02000 0.01958
12 Corresponds Corresponds 5.7 27.5 0.29951 0.01999 0.01957
18 Corresponds Corresponds 5.6 27.6 0.29951 0.01987 0.01955
24 Corresponds Corresponds 5.7 27.7 0.29951 0.01987 0.01954
Batch 3
0 Corresponds Corresponds 5.4 26.1 0.29949 0.01999 0.01998
3 Corresponds Corresponds 5.4 26.2 0.29939 0.01999 0.01997
6 Corresponds Corresponds 5.5 26.2 0.29950 0.01999 0.01999
9 Corresponds Corresponds 5.5 26.1 0.29939 0.01999 0.01995
12 Corresponds Corresponds 5.6 26.2 0.29921 0.01999 0.01993
18 Corresponds Corresponds 5.6 26.2 0.29926 0.01989 0.01993
24 Corresponds Corresponds 5.6 26.1 0.29926 0.01989 0.01992
